| For: | Ma SX, Li L, Cai H, Guo TK, Zhang LS. Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review. World J Clin Oncol 2023; 14(2): 81-88 [PMID: 36908678 DOI: 10.5306/wjco.v14.i2.81] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v14/i2/81.htm |
| Number | Citing Articles |
| 1 |
Zhan-Cheng Gao, Shu-Ming Guo, Zhi-Ming Shi, Chun-Yan Wu, Peng Liu, Dong-Dong Ti. Host and gut microbiota crosstalk: A new paradigm for colorectal cancer immunotherapy. World Journal of Clinical Oncology 2026; 17(4): 118606 doi: 10.5306/wjco.v17.i4.118606
|
| 2 |
Ke Xin Lin, Alexandra C. Istl, Douglas Quan, Anton Skaro, Ephraim Tang, Xiufen Zheng. PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies. Cancer Immunology, Immunotherapy 2023; 72(12) doi: 10.1007/s00262-023-03520-5
|
| 3 |
Dinh T. P. Le, Tuan D. Pham. Colorectal cancer worldwide: epidemiological trends, economic burden, and the promise of AI-driven solutions. Exploration of Medicine 2025; 6 doi: 10.37349/emed.2025.1001371
|
| 4 |
Dalia Martinez-Marin, Rebecca A. Helmer, Gurvinder Kaur, Rachel L. Washburn, Raul Martinez-Zaguilan, Souad R. Sennone, Jannette M. Dufour, Beverly S. Chilton, Zhiming Li. Helicase-like transcription factor (HLTF)-deleted CDX/TME model of colorectal cancer increased transcription of oxidative phosphorylation genes and diverted glycolysis to boost S-glutathionylation in lymphatic intravascular metastatic niches. PLOS ONE 2023; 18(9) doi: 10.1371/journal.pone.0291023
|
| 5 |
Sarah J. Greenstein, Charmaine A. Ramlogan-Steel, Ingrid A. Wise, Rebecca J. Wilson, Jason C. Steel. PRL-3 as a metastasis-associated phosphatase in colorectal cancer: Mechanisms and therapeutic strategies. Clinical & Experimental Metastasis 2025; 43(1) doi: 10.1007/s10585-025-10385-8
|
| 6 |
Gudrun Thorhallsdottir, Ramon Benz, Pinuccia Faviana, Francesco Bartoli, Natascia Leonardi, Ivann Sekielyk, Laura Fetriconi, Samuele Cazzamalli, Emanuele Puca, Dario Neri, Abdullah Elsayed. Targeted TNF Potentiates the Activity of Bispecific T-cell Engagers in Solid Tumors by Turning Cold Tumors Hot. Cancer Immunology Research 2026; 14(6) doi: 10.1158/2326-6066.CIR-25-1572
|
| 7 |
Karla K Frietze, Kamala Anumukonda, Laura Padula, Natasha Strbo, Neil Goldstein. Directed protein engineering identifies a human TIM-4 blocking antibody that enhances anti-tumor response to checkpoint inhibition in murine colon carcinoma. Antibody Therapeutics 2024; 7(4) doi: 10.1093/abt/tbae026
|
| 8 |
Danlei Zhou, Yujing Sun, Peipei Ding, Xiaochao Wang, Ling Li, Luying Li, Xinyue Lv, Tian Liao, Jianfeng Chen, Wei Zhang, Qi Wang, Qing-Hai Ji, Feng Gao, Weiguo Hu, Jan Claesen, Huoxiang Zhou. Gut commensal bacteria influence colorectal cancer development by modulating immune response in AOM/DSS-treated mice. Microbiology Spectrum 2025; 13(7) doi: 10.1128/spectrum.02792-24
|
| 9 |
Tatiana Sudarskikh, Kseniia Shalygina, Elena Shmakova, Pavel Iamshchikov, Alexey Dobrodeev, Irina Larionova, Julia Kzhyshkowska. Macrophages as predictors and new targets for immunotherapy in colorectal cancer. Exploration of Digestive Diseases 2026; 5 doi: 10.37349/edd.2026.1005124
|
| 10 |
Abhishek Kumar, Dyumn Dwivedi, Neha Ghosh, Kesavaperumal Gopalakrishnan, Mohamed Rahamathulla, Mohammed Muqtader Ahmed, Chandralekha Nair, Dewang Singh, Randhir Singh, Uddalak Das. iPSC-derived polyvalent vaccines as ontogenetically informed immunogens toward overcoming immune refractoriness in microsatellite-stable colorectal cancer: An emerging frontier in cancer immunotherapy. Molecular Immunology 2026; 198 doi: 10.1016/j.molimm.2026.08.008
|
| 11 |
Xiaoyu Li, Lihua Zhang, Wenwen Min. Enhancing Super‐Resolution Spatial Transcriptomics Data by Transfer Learning. Advanced Science 2026; doi: 10.1002/advs.76601
|
| 12 |
Abdullah Elsayed, Louis Plüss, Larissa Nideroest, Giulia Rotta, Marina Thoma, Nathan Zangger, Frederik Peissert, Stefanie K. Pfister, Christian Pellegrino, Sheila Dakhel Plaza, Roberto De Luca, Markus G. Manz, Annette Oxenius, Emanuele Puca, Cornelia Halin, Dario Neri. Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer. Molecular Cancer Therapeutics 2024; 23(7) doi: 10.1158/1535-7163.MCT-23-0766
|
| 13 |
Jin’e Du, Zhichao Guo, Qiao Lu, Huiqin Guo, Fengming Liu, Zhaoying Hao, Yiwei Duan, Zhuoyu Li, Haili Wu. LncRNA 606938-TFAM axis drives oxidative stress and activates cGAS-STING pathway-mediated antitumor immunity to restrain colorectal cancer progression. Oncogene 2026; 45(27) doi: 10.1038/s41388-026-03839-0
|
| 14 |
Haonan Shen, Weichen Zhang, Gaoli Niu, Li Wang, Ruiyan Li, Yueyue Fan, Feixue Lu, Lingling Xu, Xiaoyuan Ji, Yong Kang. From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy. BMEMat 2026; doi: 10.1002/bmm2.70130
|
| 15 |
Jiawen Weng, Huangjin Luo, Tong Gao, Yichi Zhang, Yingting Zhuang, Yongmei Dai. Comprehensive profiling of alternative splicing and immune landscapes in rectal cancer: implications for mRNA vaccine design and immune subtype stratification. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1780631
|